C

Cell Biotech Co Ltd
KOSDAQ:049960

Watchlist Manager
Cell Biotech Co Ltd
KOSDAQ:049960
Watchlist
Price: 13 020 KRW 1.56% Market Closed
Market Cap: 89.1B KRW

Operating Margin

11.8%
Current
Improving
by 2%
vs 3-y average of 9.8%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
11.8%
=
Operating Income
₩6B
/
Revenue
₩50.6B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
11.8%
=
Operating Income
₩6B
/
Revenue
₩50.6B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
Cell Biotech Co Ltd
KOSDAQ:049960
89.1B KRW
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
378.3B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
178.1B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
154.2B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.3B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.3B USD
Loading...
AU
CSL Ltd
ASX:CSL
85.3B AUD
Loading...
NL
argenx SE
XBRU:ARGX
41.9B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
46.9B USD
Loading...
No Stocks Found

Market Distribution

Higher than 83% of companies in Korea
Percentile
83rd
Based on 2 615 companies
83rd percentile
11.8%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

Cell Biotech Co Ltd
Glance View

Market Cap
89.1B KRW
Industry
Biotechnology

Cell Biotech Co., Ltd. engages in the manufacture, research and development of probiotics lactobacillus products. The company is headquartered in Gimpo, Gyeonggi-Do. The company went IPO on 2002-12-13. The firm's products include lactic acid bacteria (LAB) powders and finished products containing LABs. Its LAB powders are used as raw materials in foods and medicines for the functions of immunization enhancement and digestion improvement. Its finished products containing LABs are used for intestinal health improvement, carcinogen inhibition, calcium supplement and others. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
11 560.25 KRW
Overvaluation 11%
Intrinsic Value
Price
C
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
11.8%
=
Operating Income
₩6B
/
Revenue
₩50.6B
What is Cell Biotech Co Ltd's current Operating Margin?

The current Operating Margin for Cell Biotech Co Ltd is 11.8%, which is above its 3-year median of 9.8%.

How has Operating Margin changed over time?

Over the last 3 years, Cell Biotech Co Ltd’s Operating Margin has decreased from 14.1% to 11.8%. During this period, it reached a low of 2.4% on Sep 30, 2023 and a high of 15.3% on Sep 30, 2024.

Back to Top